Mariya N. Ryabinina

Clopidogrel Response Variability: Impact of Genetic Polymorphism and Platelet Biomarkers for Predicting Adverse Outcomes Poststenting

V. Serebruany, E. Golukhova, N. Bulaeva, 2015, American journal of therapeutics.

Body Mass Index and Plasma P-Selectin before Coronary Stenting Predict High Residual Platelet Reactivity at 6 Months on Dual Antiplatelet Therapy

V. Serebruany, E. Golukhova, N. Bulaeva, 2018, Cardiology.

Independent Predictors of Major Adverse Events following Coronary Stenting over 28 Months of Follow-Up

V. Serebruany, E. Golukhova, N. Bulaeva, 2015, Cardiology.